Low-dose aspirin for prevention of pre-eclampsia: when over the counter just isn’t
This editorial discusses the clear, evidence-based role for low-dose aspirin in reducing pre-eclampsia in pregnant women at risk of this condition, and argues that developing a national PGD to allow community pharmacists to supply it would help to increase uptake.
Source:
Drug and Therapeutics Bulletin